Company Filing History:
Years Active: 2010
Title: Mukund Seshadri: Innovator in Cancer Therapy Optimization
Introduction
Mukund Seshadri is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of cancer therapy through his innovative methods. His work focuses on optimizing the administration of chemotherapeutic agents, which can greatly enhance treatment outcomes for patients.
Latest Patents
Mukund Seshadri holds a patent for a method titled "Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium." This invention provides a novel approach to optimizing the regimen for administering chemotherapeutic agents. The method involves administering a selenium compound to an individual and monitoring the modulation of tumor vessel maturation (TVM) to identify the optimal time for chemotherapy administration. Additionally, this invention offers a way to determine whether a tumor is likely to respond to chemotherapy by observing an increase in TVM following selenium administration.
Career Highlights
Mukund Seshadri is associated with Health Research, Inc., where he continues to advance research in cancer therapy. His work is pivotal in developing strategies that can lead to more effective treatment protocols for cancer patients.
Collaborations
He has collaborated with esteemed colleagues such as Youcef M Rustum and Arup Bhattacharya, contributing to a rich environment of innovation and research.
Conclusion
Mukund Seshadri's contributions to cancer therapy optimization through his patented methods highlight the importance of innovative approaches in medical research. His work not only aims to improve treatment efficacy but also enhances the understanding of tumor biology.